ETF PRO AIOctober 2, 2026
IDNA iShares Genomics Immunology and Healthcare ETF
Fund tearsheet · data as of the latest session · October 2, 2026
ONE YEAR OF DAILY CLOSES
0.47%expense ratio
$299Mfund assets
+59.0%return, YTD
+71.1%return, 1 year
+$20Mnet flow, 1 month
+$75Mnet flow, 1 year
28.3%realized volatility, 1y
-10.7%worst drawdown, 1y
Top ten holdings
| 1 | MRNA MODERNA | 11.84% |
| 2 | TWST TWIST BIOSCIENCE | 7.42% |
| 3 | GSK GSK | 2.61% |
| 4 | IOVA IOVANCE BIOTHERAPEUTICS | 4.86% |
| 5 | RVMD REVOLUTION MEDICINES | 3.78% |
| 6 | MRK MERCK & CO | 3.41% |
| 7 | REGN REGENERON PHARMACEUTICALS | 3.26% |
| 8 | INCY INCYTE | 3.32% |
| 9 | VRTX VERTEX PHARMACEUTICALS | 3.25% |
| 10 | EXEL EXELIXIS | 3.07% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS